Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. biotechs can’t shake October blues as investors await next moves
U.S. biotechs can’t shake October blues as investors await next moves
U.S. biotechs can’t shake October blues as investors await next moves
Submitted by
admin
on November 19, 2017 - 9:53am
Source:
Globe and Mail, Canada
News Tags:
biotech
investors
Biogen
Gilead Sciences
Celgene
Headline:
U.S. biotechs can’t shake October blues as investors await next moves
Do Not Allow Advertisers to Use My Personal information
